IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.

Saved in:
Bibliographic Details
Title: IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.
Authors: Sim GC, Martin-Orozco N, Jin L, Yang Y, Wu S, Washington E, Sanders D, Lacey C, Wang Y, Vence L, Hwu P, Radvanyi L
Source: The Journal of clinical investigation [J Clin Invest] 2014 Jan; Vol. 124 (1), pp. 99-110.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI46266